What do you mean "who care", you made the incorrect statement so don't you care??? Like I told you, both stocks are in a totally different market and regulatory are more strict on NDA as they should be than whatever product TRP is selling, that's why it cost $10o of millions and even billions for the kind of Ph3 clinical trials. And like I told you, clearly PH wants all the IP at a development stage to sell the entire company, this is when IMU will get maximum return for IMU
IMUGENE CHART. TA only, page-33820
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
0.001(0.94%) |
Mkt cap ! $394.1M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.4¢ | 5.3¢ | $12.42K | 234.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 34 | 6212077 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 1215760 | 14 |
View Market Depth
| Last trade - 10.10am 11/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |